Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures

被引:4
|
作者
Huo, Chen [1 ]
Zhang, Meng-Yu [1 ]
Li, Rui [1 ]
Liu, Ting-Ting [1 ]
Li, Jian-Ping [1 ]
Qu, Yi-Qing [2 ]
机构
[1] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Pulm & Crit Care Med,Shandong Key Lab Infect, Jinan, Peoples R China
[2] Shandong Univ, Qilu Hosp, Dept Pulm & Crit Care Med, Shandong Key Lab Infect Resp Dis, Jinan, Peoples R China
来源
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2021年 / 9卷
关键词
lung adenocarcinoma; glycolysis; tumor mutational burdens; prognosis; tumor-infiltrating immune cell; INTERACTION NETWORKS; CANCER; TUMORS; INHIBITION; RESISTANCE;
D O I
10.3389/fcell.2021.645482
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Increasing studies have proved that malignant tumors are associated with energy metabolism. This study was aimed to explore biological variables that impact the prognosis of patients in the glycolysis-related subgroups of lung adenocarcinoma (LUAD). The mRNA expression profiling and mutation data in large LUAD samples were collected from the Cancer Genome Atlas (TCGA) database. Then, we identified the expression level and prognostic value of glycolysis-related genes, as well as the fractions of 22 immune cells in the tumor microenvironment. The differences between glycolysis activity, mutation, and immune infiltrates were discussed in these groups, respectively. Two hundred fifty-five glycolysis-related genes were identified from gene set enrichment analysis (GSEA), of which 43 genes had prognostic values (p < 0.05). Next, we constructed a glycolysis-related competing endogenous RNA (ceRNA) network which related to the survival of LUAD. Then, two subgroups of LUAD (clusters 1 and 2) were identified by applying unsupervised consensus clustering to 43 glycolysis-related genes. The survival analysis showed that the cluster 1 patients had a worse prognosis (p < 0.001), and upregulated differentially expressed genes (DEGs) are interestingly enriched in malignancy-related biological processes. The differences between the two subgroups are SPTA1, KEAP1, USH2A, and KRAS among top 10 mutated signatures, which may be the underlying mechanism of grouping. Combined high tumor mutational burden (TMB) with tumor subgroups preferably predicts the prognosis of LUAD patients. The CIBERSORT algorithm results revealed that low TMB samples were concerned with increased infiltration level of memory resting CD4+ T cell (p = 0.03), resting mast cells (p = 0.044), and neutrophils (p = 0.002) in cluster 1 and high TMB samples were concerned with increased infiltration level of memory B cells, plasma cells, CD4 memory-activated T cells, macrophages M1, and activated mast cells in cluster 2, while reduced infiltration of monocytes, resting dendritic cells, and resting mast cells was captured in cluster 2. In conclusion, significant different gene expression characteristics were pooled according to the two subgroups of LUAD. The combination of subgroups, TMB and tumor-infiltrating immune cell signature, might be a novel prognostic biomarker in LUAD.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Overexpression of SPP1 is a prognostic indicator of immune infiltration in lung adenocarcinoma
    Li, Binbin
    Li, Xue
    Yang, Qingfeng
    Jiang, Yiyang
    Zhang, Qianwen
    Zhang, Jingtao
    Cui, Wenqiang
    Xu, Fei
    AGING-US, 2024, 16 (03): : 2953 - 2977
  • [32] Construction of an immune-related gene prognostic model with experimental validation and analysis of immune cell infiltration in lung adenocarcinoma
    Yang, Jialei
    Tang, Chao
    Li, Chengxia
    Li, Xuesen
    Yang, Wenli
    ONCOLOGY LETTERS, 2024, 28 (01)
  • [33] Chordin-like 1 is a novel prognostic biomarker and correlative with immune cell infiltration in lung adenocarcinoma
    Deng, Bing
    Chen, Xiaorui
    Xu, Lingfang
    Zheng, Li
    Zhu, Xiaoqian
    Shi, Junwei
    Yang, Lei
    Wang, Dian
    Jiang, Depeng
    AGING-US, 2022, 14 (01): : 389 - 409
  • [34] AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma
    Ma, Chenxi
    Kang, Wenyan
    Yu, Lu
    Yang, Zongcheng
    Ding, Tian
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [35] Analyzing the characteristics of immune cell infiltration in lung adenocarcinoma via bioinformatics to predict the effect of immunotherapy
    Liao, Yi
    He, Dingxiu
    Wen, Fuqiang
    IMMUNOGENETICS, 2021, 73 (05) : 369 - 380
  • [36] Identification of subgroups and development of prognostic risk models along the glycolysis-cholesterol synthesis axis in lung adenocarcinoma
    Jiang, Jiuzhou
    Qian, Bao
    Guo, Yangjie
    He, Zhengfu
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [37] Pregnancy Zone Protein Serves as a Prognostic Marker and Favors Immune Infiltration in Lung Adenocarcinoma
    Chen, Kehong
    Zheng, Taihao
    Chen, Cai
    Liu, Liangzhong
    Guo, Zhengjun
    Peng, Yuan
    Zhang, Xiaoyue
    Yang, Zhenzhou
    BIOMEDICINES, 2023, 11 (07)
  • [38] SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma
    Xiuao Zhang
    Zhengcun Wu
    Kaili Ma
    BMC Cancer, 22
  • [39] TYK2 is a prognostic biomarker and associated with immune infiltration in the lung adenocarcinoma microenvironment
    He, Aoxiao
    Zhang, Rongguiyi
    Wang, Jiakun
    Huang, Zhihao
    Liao, Wenjun
    Li, Yong
    Wang, Cong
    Yang, Jun
    Feng, Qian
    Wu, Linquan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (02) : E129 - E140
  • [40] Systematic profiling of immune signatures identifies prognostic predictors in lung adenocarcinoma
    Mao, Shuangshuang
    Li, Yuan
    Lu, Zhiliang
    Che, Yun
    Huang, Jianbing
    Lei, Yuanyuan
    Wang, Yalong
    Wang, Xinfeng
    Liu, Chengming
    Zheng, Sufei
    Li, Ning
    Li, Jiagen
    Sun, Nan
    He, Jie
    CELLULAR ONCOLOGY, 2020, 43 (04) : 681 - 694